Bone morphogenetic protein and endometriosis

Bone morphogenetic protein  and endometriosis By Nadire Duru

Endometriosis is a chronic disease characterized by the presence of endometrial glands and stroma outside the uterus, associated with several discomforts such as pelvic pain, menstrual disorders, and infertility. Although endometriosis is categorized as a benign lesion, the ectopic endometrial…

Key Points Lay Summary

Interleukin-37b inhibits the growth of murine endometriosis-like lesions

Interleukin-37b inhibits the growth of murine endometriosis-like lesions By Nadire Duru

Endometriosis is a chronic gynecological disease that causes chronic pain and infertility in women. Despite continuous efforts and numerous research, there is, ultimately, still much to understand about the pathogenesis of endometriosis. Inflammatory factors including several interleukins have already been…

Key Points Lay Summary

Can we Inhibit the Survival of Endometriosis?

Can we Inhibit the Survival of Endometriosis? By Dr. Youngran Park

Endometriosis is an estrogen-dependent gynecological inflammatory disease. The current anti-estrogen therapies can be prescribed only for a short time due to the undesirable side effects on menstruation, pregnancy, bone health, and recurrence. Therefore, the development of specific therapy which targets…

Key Points Lay Summary

Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis.

Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis. By Dr. Youngran Park

Dr. Matsuzaki et al. (2018) published a paper entitled ‘In vitro and in vivo effects of MK2206 and chloroquine combination therapy on endometriosis’ showing that the efficacy of MK2206, an Akt inhibitor, in combination with chloroquine for inducing autophagy in…

Key Points Lay Summary

The effects of MK2206 and chloroquine combination therapy on endometriosis.

The effects of MK2206 and chloroquine combination therapy on endometriosis. By Dr. Youngran Park

Endometriosis affects approximately 10% of women of reproductive age. A high recurrence rate after medical treatment with or without surgery is a significant clinical problem for patients with endometriosis. Establishment of a complete cure for patients with endometriosis awaits new…

Key Points Lay Summary

CCL19/CCR7 Interaction can Casue Characteristic Cell Proliferation

CCL19/CCR7 Interaction can Casue Characteristic Cell Proliferation By Kasthuri Nair

In their paper published in the American Journal of Reproductive Immunology titled “CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs,” Diao et al. hope to elucidate one of the mechanisms…

Key Points Lay Summary